➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Colorcon
Medtronic
Johnson and Johnson
Mallinckrodt
Express Scripts

Last Updated: August 4, 2020

DrugPatentWatch Database Preview

SUFENTANIL CITRATE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Sufentanil Citrate patents expire, and when can generic versions of Sufentanil Citrate launch?

Sufentanil Citrate is a drug marketed by Hospira, Watson Labs, and West-ward Pharms Int. and is included in three NDAs.

The generic ingredient in SUFENTANIL CITRATE is sufentanil citrate. There are nine drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the sufentanil citrate profile page.

US ANDA Litigation and Generic Entry Outlook for Sufentanil Citrate

A generic version of SUFENTANIL CITRATE was approved as sufentanil citrate by WEST-WARD PHARMS INT on December 15th, 1995.

  Start Trial

Drug patent expirations by year for SUFENTANIL CITRATE
Recent Clinical Trials for SUFENTANIL CITRATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
West China HospitalPhase 4
Fudan UniversityN/A

See all SUFENTANIL CITRATE clinical trials

Pharmacology for SUFENTANIL CITRATE
Drug ClassOpioid Agonist
Mechanism of ActionFull Opioid Agonists
Medical Subject Heading (MeSH) Categories for SUFENTANIL CITRATE

US Patents and Regulatory Information for SUFENTANIL CITRATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira SUFENTANIL CITRATE sufentanil citrate INJECTABLE;INJECTION 074534-001 Dec 11, 1996 AP RX No No   Start Trial   Start Trial   Start Trial
Watson Labs SUFENTANIL CITRATE sufentanil citrate INJECTABLE;INJECTION 074406-001 Dec 15, 1995 DISCN No No   Start Trial   Start Trial   Start Trial
West-ward Pharms Int SUFENTANIL CITRATE sufentanil citrate INJECTABLE;INJECTION 074413-001 Dec 15, 1995 AP RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Dow
AstraZeneca
Colorcon
Medtronic
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.